does medi cal cover semaglutide California has ended adult Medi-Cal coverage for popular GLP-1 weight loss medications, leaving thousands of patients worried about losing treatment that helped control diabetes, prevent disease and change their lives. Doctors warn California's cuts to weight loss

However, the regulatory framework for drug development relies heavily on animal toxicology precisely because it does provide meaningful safety signals

1 Medications such as liraglutide, semaglutide, exenatide, and dulaglutide are classified as glucagon-like peptide-1 (GLP-1) receptor agonists that work by increasing glucose-dependent insulin secretion, slowing gastric emptying, and decreasing inappropriate glucagon secretion

The drug information provided here is only a summary and does not contain all the list of possible side effects and drug interactions regarding this medication

334-OR: pemvidutide (ALT-801), a balanced (1: 1) GLP-1/glucagon dual receptor agonist, induces rapid and marked weight loss without the need for dose titration in people with overweight/obesity

There are standard dosage protocols for Ozempic and Wegovy, the most popular forms of taking the drug